Similarly, overexpression of another receptor tyrosine kinase (RTK) EGFR, has been noted in gastric cancer and multiple trials of EGFR inhibitors in this cancer type are ongoing (reviewed in [9,10]). This evidence concerns the gene NTRK1 and cancer.